Extraction-Free RT-PCR Surveillance Testing and Reporting for SARS-CoV-2

Author:

Carney Patrick R.12ORCID,Duellman Tyler3,Chan Jia-Yi3,Wells Lauren3,Tessmer Michael4,Frater-Rubsam Leah3ORCID,Zeller Molly3ORCID,Field Mark4,Speers James3ORCID,Tyrrell Kelly5,Thompson Luke6,Bondurant Michael4,Morin Tami6,Dagnon Tamra6,Goff Brian6,Runde Corissa4,Splinter-Bondurant Sandra3,Konsitzke Charles3,Kelly Patrick6,Bradfield Christopher A.123,Hyman Joshua3

Affiliation:

1. Molecular and Environmental Toxicology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, USA

2. Department of Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, USA

3. Biotechnology Center, University of Wisconsin-Madison, Madison, WI 53706, USA

4. Division of Information Technology, University of Wisconsin-Madison, Madison, WI 53706, USA

5. University Communications, University of Wisconsin-Madison, Madison, WI 53706, USA

6. University Health Services, University of Wisconsin-Madison, Madison, WI 53706, USA

Abstract

The COVID-19 pandemic necessitated sensitive, fast, and inexpensive testing for the virus in 2020 prior to the widespread availability of vaccines. Early testing efforts were limited by bottlenecks on reagents, low-throughput testing options, and the slow return of test results. In this paper, we detail the testing pipeline we established at the University of Wisconsin-Madison for rapid, inexpensive, and sensitive surveillance testing for SARS-CoV-2, and we highlight the strengths of the platform that would allow it to be applied to other disease surveillance projects, SARS-CoV-2 variant testing, or future pandemics. This pipeline can be quickly established for further accreditation and clinical application.

Funder

National Institutes of Health

Publisher

MDPI AG

Subject

General Medicine

Reference16 articles.

1. (2021, April 21). Naming the Coronavirus Disease (COVID-19) and the Virus That Causes It. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.

2. (2021, April 21). CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, Available online: https://www.fda.gov/media/134922/download.

3. Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials;Senff;J. Clin. Virol.,2020

4. Implementation of an Extraction-Free COVID Real-Time PCR Workflow in a Pediatric Hospital Setting;Elkan;J. Appl. Lab. Med.,2021

5. Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR;Smyrlaki;Nat. Commun.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3